Steven Cohen's AVIR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 119,553 shares of Atea Pharmaceuticals, Inc. (AVIR) worth $643,195, representing 0.00% of the portfolio. First purchased in 2021-Q3, this short-term holding has been held for 7 quarters.
Based on 13F filings, Steven Cohen has maintained this position in AVIR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 63,905 shares. Largest reduction occurred in Q4 2021, reducing 332,200 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Atea Pharmaceuticals (AVIR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Atea Pharmaceuticals (AVIR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +55,648 | Add 87.08% | 119,553 | $5.38 |
| Q4 2025 | +63,905 | New Buy | 63,905 | $3.57 |
| Q3 2023 | -9 | Sold Out | 0 | $0.00 |
| Q2 2023 | -36,673 | Reduce 99.98% | 9 | $3.78 |
| Q1 2023 | +36,682 | New Buy | 36,682 | $3.35 |
| Q4 2021 | -332,200 | Sold Out | 0 | $0.00 |
| Q3 2021 | +332,200 | New Buy | 332,200 | $35.06 |
Steven Cohen's Atea Pharmaceuticals Investment FAQs
Steven Cohen first purchased Atea Pharmaceuticals, Inc. (AVIR) in Q3 2021, acquiring 332,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Atea Pharmaceuticals, Inc. (AVIR) for 7 quarters since Q3 2021.
Steven Cohen's largest addition to Atea Pharmaceuticals, Inc. (AVIR) was in Q3 2021, adding 332,200 shares worth $11.65 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 119,553 shares of Atea Pharmaceuticals, Inc. (AVIR), valued at approximately $643,195.
As of the Q1 2026 filing, Atea Pharmaceuticals, Inc. (AVIR) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Atea Pharmaceuticals, Inc. (AVIR) was 332,200 shares, as reported at the end of Q3 2021.